ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
("the Company" or "Advanced")
ISIN Code: ZAE000189049 | JSE Code: AVL |
UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2021
HIGHLIGHTS
- Profit after tax for the period is reported at R0.8 million (2020: (loss 9.8 million))
- Revenue decreased by 6% to R321.1 million (2020: R340.1 million).
- Cash generated from operations increased by 11% to R80.8 million (2020: R73.1 million).
- Basic loss per share improved by 3.1% to 2.81 cents (2020: basic loss per share of 2.90 cents).
- Headline loss per share increased by 30.1% to 2.81 cents (2020: headline loss per share of 2.16).
No dividend were proposed for the current period.
Short-form announcement
The contents of the short-form announcement are the responsibility of the Board of Directors of Advanced Health Limited. The information in the short-form announcement is a summary of the full announcement and accordingly does not contain full or complete details. The full announcement is available for inspection at no charge, Monday to Friday, during office hours at the company's registered office, the office of the Designated Advisor and on the Company's website on http://www.advancedhealth.co.za/from 25 February 2022. The full announcement is available on SENS from 25 February 2022 at https://senspdf.jse.co.za/documents/2022/jse/isse/AVL/DEC2021AVL.pdf.
The information in this announcement has been extracted from the unaudited condensed consolidated interim financial statements for the six months ended 31 December 2021 and the short-form announcement itself has not been reviewed by the Company's auditors. Any investment decisions by shareholders/investors should be based on the full announcement released to the JSE and published on the Company's website.
CORPORATE INFORMATION | |
Advanced Health Limited | Registered Address: |
(Incorporated in the Republic of South Africa) | Building 2, Walker Creek Office Park |
Registration number: 2013/059246/06 | 90 Florence Ribeiro Avenue |
ISIN: ZAE000189049 JSE Code: AVL | Muckleneuk |
0002 | |
Postnet Suite 668, Private Bag X1 | |
The Willows, 0041 |
Executive directors | Non-Executive Directors |
GJ van Emmenis (Chief Executive Officer) | FA van Hoogstraten (Lead Independent) |
MC Resnik# (Managing Director - Australia) | CA Grillenberger (Chairman) |
D Goss-Ross (Managing Director - South Africa) | PJ Jaffe # |
S Chonco (Chief Financial Officer) | CJPG van Zyl |
Dr WT Mthembu | ||
YJ Visser | ||
Dr KE Legodi | ||
# Australian | ||
Company Secretary: | M Janse van Rensburg | |
Auditors: | Mazars | |
Transfer Secretaries: | Link Market Services Proprietary Limited | |
Date of announcement: 25 February 2022
Designated Advisor
Grindrod Bank Limited
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Advanced Health Limited published this content on 25 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 February 2022 12:59:53 UTC.